Literature DB >> 17643462

Antigen-induced regulatory T cells in HBV chronically infected patients.

Luisa Barboza1, Siham Salmen, Loredana Goncalves, Melisa Colmenares, Darrell Peterson, Henry Montes, Raimondo Cartagirone, Maria del Carmen Gutiérrez, Lisbeth Berrueta.   

Abstract

T cell response against HBV is vigorous in patients with acute hepatitis who clear the virus, whereas it is weak and narrowly focused in patients with chronic disease. We report that following incubation with HBcAg, a population of CD4+FoxP3+ cells expressing phenotypic markers of both natural and induced Tregs, can be antigen-induced from peripheral mononuclear cells. Conversely, naive and naturally immune subjects did not increase CD4+FoxP3+ Tregs following stimulation with HBcAg, supporting the idea that natural Tregs are able to respond specifically to HBV antigen. Furthermore, increased frequencies of antigen-induced CD4+FoxP3+IL-10+ Tregs correlated with viral load, suggesting that antigen-induced Tregs could contribute to an inadequate response against the virus, leading to chronic infection and support the view that specific natural Tregs may be implicated in host immune tolerance during HBV infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17643462     DOI: 10.1016/j.virol.2007.06.030

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  Virus expanded regulatory T cells control disease severity in the Theiler's virus mouse model of MS.

Authors:  Maureen H Richards; Meghann Teague Getts; Joseph R Podojil; Young-Hee Jin; Byung S Kim; Stephen D Miller
Journal:  J Autoimmun       Date:  2011-01-26       Impact factor: 7.094

2.  Identification of a unique double-negative regulatory T-cell population.

Authors:  Byung O Lee; Joyce E Jones; Cory J Peters; David Whitacre; Lars Frelin; Janice Hughes; Won-Keun Kim; David R Milich
Journal:  Immunology       Date:  2011-12       Impact factor: 7.397

3.  Amphiregulin promotes the immunosuppressive activity of intrahepatic CD4+ regulatory T cells to impair CD8+ T-cell immunity against hepatitis B virus infection.

Authors:  Kai Dai; Ling Huang; Jing Chen; Lihua Yang; Zuojiong Gong
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

4.  Inhibition of viral replication downregulates CD4(+)CD25(high) regulatory T cells and programmed death-ligand 1 in chronic hepatitis B.

Authors:  Xue-Ping Nan; Ye Zhang; Hai-Tao Yu; Rui-Lin Sun; Mei-Juan Peng; Yu Li; Wen-Jing Su; Jian-Qi Lian; Jiu-Ping Wang; Xue-Fan Bai
Journal:  Viral Immunol       Date:  2012-01-10       Impact factor: 2.257

5.  Immunopathogenesis of hepatitis B persistent infection: implications for immunotherapeutic strategies.

Authors:  Yasuteru Kondo; Yoshiyuki Ueno; Tooru Shimosegawa
Journal:  Clin J Gastroenterol       Date:  2009-03-27

6.  T follicular helper cells improve the response of patients with chronic hepatitis B to interferon by promoting HBsAb production.

Authors:  Yong Liu; Xintong Hu; Xiaoli Hu; Lei Yu; Huifan Ji; Wanyu Li; Yanjun Cai; Genhong Cheng; Yanfang Jiang
Journal:  J Gastroenterol       Date:  2022-01-06       Impact factor: 7.527

7.  Treatment of chronic viral hepatitis in woodchucks by prolonged intrahepatic expression of interleukin-12.

Authors:  Julien Crettaz; Itziar Otano; Laura Ochoa-Callejero; Laura Ochoa; Alberto Benito; Astrid Paneda; Igor Aurrekoetxea; Pedro Berraondo; Juan Roberto Rodríguez-Madoz; Aurora Astudillo; Florian Kreppel; Stefan Kochanek; Juan Ruiz; Stephan Menne; Jesus Prieto; Gloria Gonzalez-Aseguinolaza
Journal:  J Virol       Date:  2008-12-30       Impact factor: 5.103

8.  Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection.

Authors:  James S Cavenaugh; Dorka Awi; Maimuna Mendy; Adrian V S Hill; Hilton Whittle; Samuel J McConkey
Journal:  PLoS One       Date:  2011-02-15       Impact factor: 3.240

Review 9.  Fallen angels or risen apes? A tale of the intricate complexities of imbalanced immune responses in the pathogenesis and progression of immune-mediated and viral cancers.

Authors:  Beatrice Omusiro Ondondo
Journal:  Front Immunol       Date:  2014-03-06       Impact factor: 7.561

10.  A novel cytomegalovirus-induced regulatory-type T-cell subset increases in size during older life and links virus-specific immunity to vascular pathology.

Authors:  Nadia Terrazzini; Martha Bajwa; Serena Vita; Elizabeth Cheek; David Thomas; Nabila Seddiki; Helen Smith; Florian Kern
Journal:  J Infect Dis       Date:  2013-11-07       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.